CTU Insider Trading Activity and SEC Form 4 Filings
CTU insider trading summary
No open-market insider purchases or sales of Chad Therapeutics Inc (CTU) have been reported on SEC Form 4 in the past 12 months.
Latest CTU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 28, 2007 | Erika Laskey | Sr. VP of Sales/Marketing | Sell | $13K (8,046 @ $1.65) |
| Feb 26, 2007 | Erika Laskey | Sr. VP of Sales/Marketing | Sell | $13K (8,046 @ $1.60) |
| Feb 22, 2007 | Erika Laskey | Sr. VP of Sales/Marketing | Sell | $10K (6,419 @ $1.59) |
| Feb 21, 2007 | Thomas E Jones | Chairman | Buy | $2K (1,470 @ $1.70) |
| Feb 15, 2007 | Erika Laskey | Sr. VP of Sales/Marketing | Sell | $9K (5,628 @ $1.67) |
| Jan 2, 2007 | Kevin McCulloh | VP of Engineering | Sell | $20K (8,327 @ $2.40) |
| Dec 6, 2006 | Kevin McCulloh | VP of Engineering | Sell | $8K (2,627 @ $2.87) |
| Nov 24, 2006 | John C Boyd | Director | Sell | $2K (650 @ $3.07) |
| Nov 24, 2006 | John C Boyd | Director | Sell | $5K (1,823 @ $2.99) |
| Aug 15, 2006 | Earl L Yager | President and CEO | Buy | $15K (10,000 @ $1.53) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.